Research Projects
Integration of 4-1BB (CD 137) agonists, interleukin-12, interleukin-18, and TGF-beta antagonists in synergistic combination strategies for cancer immunotherapy.
Senior Researcher | Principal Investigator
Combination Strategies for Translational Immunotherapy Research Group
Research program
Immunology and Immunotherapy
Research group
Combined translational immunotherapy strategies
Disease
Cancer
Project information
Grant for pre-doctoral contracts for the training of doctors awarded to Gabriel Gomis Cobos to carry out the research entitled: "Integration of 4-1BB (CD 137) agonists, interleukin-12, interleukin-18 and TGF-beta antagonists in combined synergistic strategies for cancer immunotherapy".
This research is directed by Ignacio Melero, principal investigator of the Combined Translational Immunotherapy Strategies Research Group within the Immunology and Immunotherapy Programme.
PRE2021-100607, financed by MCIN/AEI/10.13039/501100011033 and by ESF+
- Convocation: Grants for pre-doctoral contracts for the training of PhDs
- Reference: PRE2021-100607
- Start date: September 1, 2022
- End date: August 31, 2026
- Funder: Ministerio de Ciencia e Innovación
- Nature of project: National
- Award year 2022
Need more information?
If you are interested in learning more about our research, please contact us.